3,793
Views
4
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Paper

Evolving measles status and immunization policy development in six European countries

ORCID Icon, ORCID Icon, & ORCID Icon
Article: 2031776 | Received 29 Oct 2021, Accepted 11 Jan 2022, Published online: 18 Feb 2022

References

  • Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL. Global control and regional elimination of measles, 2000-2012. MMWR Morb Mortal Wkly Rep. 2014;63:103–15.
  • Patel MK, Antoni S, Nedelec Y, Sodha S, Menning L, Ogbuanu IU, Gacic Dobo M. The changing global epidemiology of measles, 2013-2018. J Infect Dis. 2020;222:1117–28. doi:10.1093/infdis/jiaa044.
  • Zimmerman LA, Muscat M, Singh S, Ben Mamou M, Jankovic D, Datta S, Alexander JP, Goodson JL, O’Connor P. Progress toward measles elimination - European Region, 2009-2018. MMWR Morb Mortal Wkly Rep. 2019;68:396–401. doi:10.15585/mmwr.mm6817a4.
  • Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N. Supplementary immunization activities to achieve measles elimination: experience of the European Region. J Infect Dis. 2011;204(Suppl 1):S343–52. doi:10.1093/infdis/jir074.
  • Datta SS, O’Connor PM, Jankovic D, Muscat M, Ben Mamou MC, Singh S, Kaloumenos T, Reef S, Papania M, Butler R. Progress and challenges in measles and rubella elimination in the WHO European Region. Vaccine. 2018;36:5408–15. doi:10.1016/j.vaccine.2017.06.042.
  • ECDC. Surveillance Report. Measles. Annual Epidemiological Report for 2018. https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2018.
  • Bechini A, Boccalini S, Ninci A, Zanobini P, Sartor G, Bonaccorsi G, Grazzini M, Bonanni P. Childhood vaccination coverage in Europe: impact of different public health policies. Expert Rev Vaccines. 2019;18:693–701. doi:10.1080/14760584.2019.1639502.
  • Wilder-Smith AB, Qureshi K. Resurgence of measles in Europe: a systematic review on parental attitudes and beliefs of measles vaccine. J Epidemiol Glob Health. 2020;10:46–58. doi:10.2991/jegh.k.191117.001.
  • de Figueiredo A, Karafillakis E, and Larson HJ. State of Vaccine Confidence in the EU+UK 2020: report for the European Commission. Luxembourg: Publications Office of the European Union; 2020. https://ec.europa.eu/health/sites/default/files/vaccination/docs/2020_confidence_rep_en.pdf.
  • Bozzola E, Spina G, Russo R, Bozzola M, Corsello G, Villani A. Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. Ital J Pediatr. 2018;44:67. doi:10.1186/s13052-018-0504-y.
  • Holzmann H, Wiedermann U. Mandatory vaccination: suited to enhance vaccination coverage in Europe? Euro Surveill. 2019;24:1900376. doi:10.2807/1560-7917.ES.2019.24.26.1900376.
  • Vaz OM, Ellingson MK, Weiss P, Jenness SM, Bardaji A, Bednarczyk RA, Omer SB. Mandatory Vaccination in Europe. Pediatrics. 2020;145:e20190620. doi:10.1542/peds.2019-0620.
  • Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533–44. doi:10.1007/s10488-013-0528-y.
  • Nowell LS, Norris JM, White DE, and Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Meth. 2017;16:1–13. doi:10.1177/1609406917733847.
  • Gilson Gwa L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan. 1994;9:353–70. doi:10.1093/heapol/9.4.353.
  • WHO. WHO vaccine-preventable diseases: monitoring system. 2020 global summary. https://apps.who.int/immunization_monitoring/globalsummary.
  • Rodyna R. Measles situation in Ukraine during the period 2017-2019. Eur J Public Health. 2019;29. doi:10.1093/eurpub/ckz186.496.
  • Smiianov VA, Kurhanska VA, Smiianova OI. Measles outbreaks: they are preventable but keep progressing dangerously. Wiad Lek. 2019;72:2145–48. doi:10.36740/WLek201911115.
  • IFRC. Ukraine: measles outbreak DREF operation n° MDRUA009 Final Report (December 2019). https://reliefweb.int/report/ukraine/ukraine-measles-outbreak-dref-operation-n-mdrua009-final-report.
  • WHO-Europe. Measles and rubella country profile – Ukraine. 2019. [ 2013-2017]. https://www.euro.who.int/en/countries/ukraine/data-and-statistics/measles-and-rubella-country-profile-ukraine-2019.
  • WHO-Europe. Measles and rubella elimination country profile – Ukraine. 2020. [2014-2018]. https://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/surveillance-and-data/measles-and-rubella-elimination-country-profiles/2020/measles-and-rubella-elimination-country-profile-ukraine-2020
  • ECDC. Measles: recommended vaccinations. ECDC. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=8&SelectedCountryIdByDisease=−1.
  • Public-Health-England. The complete routine immunisation schedule from June 2020 (for infants born on or after 1 January 2020). https://www.gov.uk/government/publications/the-complete-routine-immunisation-schedule.
  • Rechel B, Richardson E, McKee M. The organization and delivery of vaccination services in the European Union. European Observatory on Health Systems and Policies. WHO Europe, 2020. 2018. https://apps.who.int/iris/handle/10665/330345.
  • Adamo G, Sturabotti G, Baccolini V, de Soccio P, Prencipe GP, Bella A, Magurano F, Iannazzo S, Villari P, Marzuillo C. Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal. PLoS One. 2018;13(10):e0205147. doi:10.1371/journal.pone.0205147.
  • Montalti M, Kawalec A, Leoni E, Dallolio L. Measles immunization policies and vaccination coverage in EU/EEA countries over the last decade. Vaccines (Basel). 2020;8(1):86. doi:10.3390/vaccines8010086.
  • D’Ancona F, D’Amario C, Maraglino F, Rezza G, Iannazzo S. The law on compulsory vaccination in Italy: an update 2 years after the introduction. Euro Surveill. 2019;24(26). doi:10.2807/1560-7917.ES.2019.24.26.1900371.
  • Adamo G, Baccolini V, Massimi A, Barbato D, Cocchiara R, Di Paolo C, Mele A, Cianfanelli S, Angelozzi A, Castellani F, et al. Towards elimination of measles and rubella in Italy: progress and challenges. PLoS One. 2019;14(12):e0226513. doi:10.1371/journal.pone.0226513.
  • Magurano F, Fortuna C, Baggieri M, Filia A, Benedetti E, Bucci P, Marchi A, Nicoletti L. Molecular epidemiology of measles virus in Italy during 2008. Ann Ist Super Sanita. 2013;49:50–55. doi:10.4415/ANN_13_01_09.
  • Filia A, Bella A, Rota M, Tavilla A, Magurano F, Baggieri M, Nicoletti L, Iannazzo S, Pompa MG, Declich S. Analysis of national measles surveillance data in Italy from October 2010 to December 2011 and priorities for reaching the 2015 measles elimination goal. Euro Surveill. 2013;18(20):20480. doi:10.2807/ese.18.20.20480-en.
  • Filia A, Bella A, Del Manso M, Baggieri M, Magurano F, Rota MC. Ongoing outbreak with well over 4,000 measles cases in Italy from January to end August 2017 - what is making elimination so difficult? Euro Surveill. 2017;22:30614. doi:10.2807/1560-7917.ES.2017.22.37.30614.
  • Filia A, Curtale F, Kreidl P, Morosetti G, Nicoletti L, Perrelli F, Mantovani J, Campus D, Rossi G, Sanna MC, et al. Cluster of measles cases in the Roma/Sinti population, Italy, June-September 2006. Euro Surveill. 2006;11:E061012 2. doi:10.2807/esw.11.41.03062-en.
  • Curtale F, Perrelli F, Mantovani J, Ciofi Degli Atti M, Filia A, Nicoletti L, Magurano F, Borgia P, Di Lallo D. Description of two measles outbreaks in the Lazio Region, Italy (2006-2007). Importance of pockets of low vaccine coverage in sustaining the infection. BMC Infect Dis. 2010;10(1):62. doi:10.1186/1471-2334-10-62.
  • Filia A, Amendola A, Faccini M, Del Manso M, Senatore S, Bianchi S, Borrini BM, Ciampelli A, Tanzi E, Filipponi MT, et al. Outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016. Euro Surveill. 2016;21(20):30235. doi:10.2807/1560-7917.ES.2016.21.20.30235.
  • Monasta L, Knowles A. Letter to the editor: outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016. Euro Surveill. 2016;21. doi:10.2807/1560-7917.ES.2016.21.27.30275.
  • Filia A, Faccini M, Amendola A, and Magurano F. authors of the original a. Authors’ reply: outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016. Euro Surveill. 2016;21(27):30276. doi:10.2807/1560-7917.ES.2016.21.27.30276.
  • Amendola A, Bianchi S, Frati ER, Ciceri G, Faccini M, Senatore S, Colzani D, Lamberti A, Baggieri M, Cereda D. Ongoing large measles outbreak with nosocomial transmission in Milan, northern Italy, March-August 2017. Euro Surveill. 2017;22:30596. doi:10.2807/1560-7917.ES.2017.22.33.30596.
  • Baccolini V, Sindoni A, Adamo G, Rosso A, Massimi A, Bella A, Filia A, Magurano F, Marzuillo C, Villari P, et al. Measles among healthcare workers in Italy: is it time to act? Hum Vaccin Immunother. 2020;16(11):2618–27. doi:10.1080/21645515.2020.1737458.
  • Signorelli C, Odone A, Cella P, Iannazzo S, D’Ancona F, Guerra R. Infant immunization coverage in Italy (2000-2016). Ann Ist Super Sanita. 2017;53:231–37. doi:10.4415/ANN_17_03_09.
  • Siani A. Measles outbreaks in Italy: a paradigm of the re-emergence of vaccine-preventable diseases in developed countries. Prev Med. 2019;121:99–104. doi:10.1016/j.ypmed.2019.02.011.
  • Signorelli C, Odone A. Four Italian experiences on vaccination policies: results and lessons. Ann Ig. 2019;31:36–44. doi:10.7416/ai.2019.2275.
  • Tavoschi L, Quattrone F, De Vita E, Lopalco PL. Impact of mandatory law on vaccine hesitancy spectrum: the case of measles vaccine catch-up activities in Tuscany, Italy. Vaccine. 2019;37:7201–02. doi:10.1016/j.vaccine.2019.09.092.
  • Signorelli C, Iannazzo S, Odone A. The imperative of vaccination put into practice. Lancet Infect Dis. 2018;18:26–27. doi:10.1016/S1473-3099(17)30696-5.
  • Odone A, Bucci D, Croci R, Ricco M, Affanni P, Signorelli C. Vaccine hesitancy in COVID-19 times. An update from Italy before flu season starts. Acta Biomed. 2020;91:e2020031. doi:10.23750/abm.v91i3.10549.
  • Fadda M, Galimberti E, Carraro V, Schulz PJ. What are parents’ perspectives on psychological empowerment in the MMR vaccination decision? A focus group study. BMJ Open. 2016;6:e010773. doi:10.1136/bmjopen-2015-010773.
  • Facciola A, Visalli G, Orlando A, Bertuccio MP, Spataro P, Squeri R, Picerno I, Di Pietro A. Vaccine hesitancy: an overview on parents’ opinions about vaccination and possible reasons of vaccine refusal. J Public Health Res. 2019;8:1436. doi:10.4081/jphr.2019.1436.
  • Lancella L, Di Camillo C, Vittucci AC, Boccuzzi E, Bozzola E, Villani A. Measles lessons in an anti-vaccination era: public health is a social duty, not a political option. Ital J Pediatr. 2017;43:102. doi:10.1186/s13052-017-0420-6.
  • Dalla Zuanna T, Del Manso M, Giambi C, Riccardo F, Bella A, Caporali MG, Dente M, Declich S. Immunization Offer Targeting Migrants: policies and Practices in Italy. Int J Environ Res Public Health. 2018;15:968. doi:10.3390/ijerph15050968.
  • Mipatrini D, Stefanelli P, Severoni S, Rezza G. Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence. Pathog Glob Health. 2017;111:59–68. doi:10.1080/20477724.2017.1281374.
  • Ceccarelli G, Vita S, Riva E, Cella E, Lopalco M, Antonelli F, De Cesaris M, Fogolari M, Dicuonzo G, Ciccozzi M. Susceptibility to measles in migrant population: implication for policy makers. J Travel Med. 2018;25(1):1–5. doi:10.1093/jtm/tax080.
  • Wise J. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness. BMJ. 2014;348:g2327. doi:10.1136/bmj.g2327.
  • Ramsay ME. Measles: the legacy of low vaccine coverage. Arch Dis Child. 2013;98:752–54. doi:10.1136/archdischild-2013-304292.
  • Edelstein M, White J, Bukasa A, Saliba V, Ramsay M. Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ. 2019;97:754–63. doi:10.2471/BLT.18.229138.
  • Public-Health-England. Measles and rubella elimination UK strategy. London, UK: Public Health England; 2019. https://www.gov.uk/government/publications/measles-and-rubella-elimination-uk-strategy.
  • Ghebrehewet S, Hayhurst G, Keenan A, Moore H. Outbreak of measles in Central and Eastern Cheshire, UK, October 2008-February 2009. Epidemiol Infect. 2013;141:1849–56. doi:10.1017/S0950268812002300.
  • Vivancos R, Keenan A, Farmer S, Atkinson J, Coffey E, Dardamissis E, Dillon J, Drew RJ, Fallon M, Huyton R, et al. An ongoing large outbreak of measles in Merseyside, England, January to June 2012. Euro Surveill. 2012;17:20226. doi:10.2807/ese.17.31.20234-en.
  • Keenan A, Ghebrehewet S, Vivancos R, Seddon D, MacPherson P, Hungerford D. Measles outbreaks in the UK, is it when and where, rather than if? A database cohort study of childhood population susceptibility in Liverpool, UK. BMJ Open. 2017;7(3):e014106. doi:10.1136/bmjopen-2016-014106.
  • Pegorie M, Shankar K, Welfare WS, Wilson RW, Khiroya C, Munslow G, Fiefield D, Bothra V, McCann R. Measles outbreak in Greater Manchester, England, October 2012 to September 2013: epidemiology and control. Euro Surveill. 2014;19(49):20982. doi:10.2807/1560-7917.ES2014.19.49.20982.
  • Baugh V, Figueroa J, Bosanquet J, Kemsley P, Addiman S, Turbitt D. Ongoing measles outbreak in Orthodox Jewish community, London, UK. Emerg Infect Dis. 2013;19(10):1707–09. doi:10.3201/eid1910.130258.
  • Cohuet S, Bukasa A, Heathcock R, White J, Brown K, Ramsay M, Fraser G. A measles outbreak in the Irish traveller ethnic group after attending a funeral in England, March-June 2007. Epidemiol Infect. 2009;137:1759–65. doi:10.1017/S0950268809002714.
  • Maduma-Butshe A, McCarthy N. The burden and impact of measles among the Gypsy-Traveller communities, Thames Valley, 2006-09. J Public Health (Oxf). 2013;35:27–31. doi:10.1093/pubmed/fds052.
  • Bell S, Saliba V, Ramsay M, Mounier-Jack S. What have we learnt from measles outbreaks in 3 English cities? A qualitative exploration of factors influencing vaccination uptake in Romanian and Roma Romanian communities. BMC Public Health. 2020;20:381. doi:10.1186/s12889-020-8454-x.
  • Currie J, Davies L, McCarthy J, Perry M, Moore C, Cottrell S, Bowley M, Williams C, Shankar AG, Stiff R. Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017. Euro Surveill. 2017;22:17–00673. doi:10.2807/1560-7917.ES.2017.22.42.17-00673.
  • Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Vaccine. 2014;32:1147–52. doi:10.1016/j.vaccine.2014.01.002.
  • Hungerford D, Macpherson P, Farmer S, Ghebrehewet S, Seddon D, Vivancos R, Keenan A. Effect of socioeconomic deprivation on uptake of measles, mumps and rubella vaccination in Liverpool, UK over 16 years: a longitudinal ecological study. Epidemiol Infect. 2016;144:1201–11. doi:10.1017/S0950268815002599.
  • Letley L, Rew V, Ahmed R, Habersaat KB, Paterson P, Chantler T, Saavedra-Campos M, Butler R. Tailoring immunisation programmes: using behavioural insights to identify barriers and enablers to childhood immunisations in a Jewish community in London, UK. Vaccine. 2018;36(31):4687–92. doi:10.1016/j.vaccine.2018.06.028.
  • McHale P, Keenan A, Ghebrehewet S. Reasons for measles cases not being vaccinated with MMR: investigation into parents’ and carers’ views following a large measles outbreak. Epidemiol Infect. 2016;144:870–75. doi:10.1017/S0950268815001909.
  • Edelstein M, Muller M, Ladhani S, Yarwood J, Salathe M, Ramsay M. Keep calm and carry on vaccinating: is anti-vaccination sentiment contributing to declining vaccine coverage in England? Vaccine. 2020;38:5297–304. doi:10.1016/j.vaccine.2020.05.082.
  • Draeger E, Bedford HE, Elliman DAC. Should measles vaccination be compulsory? BMJ. 2019;365:l2359. doi:10.1136/bmj.l2359.
  • Griffith R. Can the courts order that a child be immunised? Br J Nurs. 2016;25(19):1076–77. doi:10.12968/bjon.2016.25.19.1076.
  • Belgian Health Care Knowledge Centre (KCE). Performance of the Belgian health system – report 2019. https://www.healthybelgium.be/metadata/hspa/p1_p2_p3.pdf.
  • Lernout T, Kissling E, Hutse V, De Schrijver K, Top G. An outbreak of measles in orthodox Jewish communities in Antwerp, Belgium, 2007-2008: different reasons for accumulation of susceptibles. Euro Surveill. 2009;14(2):19087. doi:10.2807/ese.14.02.19087-en.
  • Asnong C, Van Herck K, Lernout T, Theeten H, Van Damme P. Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008. Pediatr Infect Dis J. 2011;30(4):343–45. doi:10.1097/INF.0b013e3181fbf5b7.
  • Braeye T, Sabbe M, Hutse V, Flipse W, Godderis L, Top G. Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011. Arch Public Health. 2013;71(1):17. doi:10.1186/0778-7367-71-17.
  • Grammens T, Schirvel C, Leenen S, Shodu N, Hutse V, Mendes da Costa E, Sabbe M. Ongoing measles outbreak in Wallonia, Belgium, December 2016 to March 2017: characteristics and challenges. Euro Surveill. 2017;22:30524. doi:10.2807/1560-7917.ES.2017.22.17.30524.
  • Cornelissen L, Grammens T, Leenen S, Schirvel C, Hutse V, Demeester R, Swennen B, Asikainen T, Wyndham-Thomas C. High number of hospitalisations and non-classical presentations: lessons learned from a measles outbreak in 2017, Belgium. Epidemiol Infect. 2020;148:e35. doi:10.1017/S0950268820000278.
  • Robert E, Dramaix M, Swennen B. Vaccination coverage for infants: cross-sectional studies in two regions of Belgium. Biomed Res Int. 2014;2014:838907. doi:10.1155/2014/838907.
  • Gobert C, Semaille P, Van der Schueren T, Verger P, Dauby N. Prevalence and Determinants of Vaccine Hesitancy and Vaccines Recommendation Discrepancies among General Practitioners in French-Speaking Parts of Belgium. Vaccines (Basel). 2021;9. doi:10.3390/vaccines9070771.
  • Hellenbrand W, Siedler A, Tischer A, Meyer C, Reiter S, Rasch G, Teichmann D, Santibanez S, Altmann D, Claus H. Progress toward measles elimination in Germany. J Infect Dis. 2003;187(Suppl 1):S208–16. doi:10.1086/368046.
  • Takla A, Wichmann O, Rieck T, Matysiak-Klose D. Measles incidence and reporting trends in Germany, 2007-2011. Bull World Health Organ. 2014;92:742–49. doi:10.2471/BLT.13.135145.
  • Siedler A, Mankertz A, Feil F, Ahlemeyer G, Hornig A, Kirchner M, Beyrer K, Dreesman J, Scharkus S, Marcic A, et al. Closer to the goal: efforts in measles elimination in Germany 2010. J Infect Dis. 2011;204(Suppl 1):S373–80. doi:10.1093/infdis/jir068.
  • Sanftenberg L, Schrors HJ, Schelling J. Influences on immunization rates: vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study. Vaccine. 2016;34:3938–41. doi:10.1016/j.vaccine.2016.06.027.
  • Storr C, Sanftenberg L, Schelling J, Heininger U, Schneider A. Measles Status-Barriers to Vaccination and Strategies for Overcoming Them. Dtsch Arztebl Int. 2018;115:723–30. doi:10.3238/arztebl.2018.0723.
  • Siedler A, Rieck T, Reuss A, Walter D, Poggensee G, Poethko-Muller C, Reiter S. Estimating vaccination coverage in the absence of immunisation registers–the German experience. Euro Surveill. 2012;17:20152. doi:10.2807/ese.17.17.20152-en.
  • Damm O, Witte J, Wetzka S, Prosser C, Braun S, Welte R, Greiner W. Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. Int J Public Health. 2016;61(7):847–60. doi:10.1007/s00038-016-0842-8.
  • Hagemann C, Streng A, Kraemer A, Liese JG. Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance. BMC Public Health. 2017;17:724. doi:10.1186/s12889-017-4725-6.
  • van Treeck U, Wichmann O. Measles outbreak in Germany: update. Euro Surveill. 2006;11:E060413 1. doi:10.2807/esw.11.15.02939-en.
  • van Treeck U. Measles outbreak in Germany: over 1000 cases now reported in Nordrhein Westfalen. Euro Surveill. 2006;11:E060511 1. doi:10.2807/esw.11.19.02955-en.
  • Wichmann O, Hellenbrand W, Sagebiel D, Santibanez S, Ahlemeyer G, Vogt G, Siedler A, van Treeck U. Large measles outbreak at a German public school, 2006. Pediatr Infect Dis J. 2007;26:782–86. doi:10.1097/INF.0b013e318060aca1.
  • Bernard H, Santibanez S, Siedler A, Ludwig MS, Fischer R, Hautmann W. An outbreak of measles in Lower Bavaria, Germany, January-June 2007. Euro Surveill. 2007;12:E071004 1. doi:10.2807/esw.12.40.03278-en.
  • Bernard H, Fischer R, Wild F. Ongoing measles outbreak in southern Bavaria, Germany. Euro Surveill. 2008;13:8002. doi:10.2807/ese.13.01.08002-en.
  • Schmid D, Holzmann H, Abele S, Kasper S, Konig S, Meusburger S, Hrabcik H, Luckner-Hornischer A, Bechter E, DeMartin A. An ongoing multi-state outbreak of measles linked to non-immune anthroposophic communities in Austria, Germany, and Norway, March-April 2008. Euro Surveill. 2008;13:18838. doi:10.2807/ese.13.16.18838-en.
  • Wadl M, Siedler A, Kramer W, Haindl ME, Gebrande S, Krenn-Lanzl I, Mankertz A, Hautmann W. Measles transmission from an anthroposophic community to the general population, Germany 2008. BMC Public Health. 2011;11(1):474. doi:10.1186/1471-2458-11-474.
  • Batzing-Feigenbaum J, Pruckner U, Beyer A, Sinn G, Dinter A, Mankertz A, Siedler A, Schubert A, Suckau M. Spotlight on measles 2010: preliminary report of an ongoing measles outbreak in a subpopulation with low vaccination coverage in Berlin, Germany, January-March 2010. Euro Surveill. 2010;15(13):19527. doi:10.2807/ese.15.13.19527-en.
  • Roggendorf H, Mankertz A, Kundt R, Roggendorf M. Spotlight on measles 2010: measles outbreak in a mainly unvaccinated community in Essen, Germany, March-June 2010. Euro Surveill. 2010;15:19605. doi:10.2807/ese.15.26.19605-en.
  • Roggendorf H, Santibanez S, Mankertz A, van Treeck U, Roggendorf M. Two consecutive measles outbreaks with genotypes D8 and D4 in two mainly unvaccinated communities in Germany. Med Microbiol Immunol. 2012;201:349–55. doi:10.1007/s00430-012-0240-7.
  • Gillesberg Lassen S, Schuster M, Stemmler M, Steinmuller A, Matysiak-Klose D, Mankertz A, Santibanez S, Wichmann O, Falkenhorst G. Measles outbreak spreading from the community to an anthroposophic school, Berlin, 2011. Epidemiol Infect. 2014;142:789–96. doi:10.1017/S0950268813001398.
  • Mankertz A, Mihneva Z, Gold H, Baumgarte S, Baillot A, Helble R, Roggendorf H, Bosevska G, Nedeljkovic J, Makowka A. Spread of measles virus D4-Hamburg, Europe, 2008-2011. Emerg Infect Dis. 2011;17:1396–401. doi:10.3201/eid1708.101994.
  • Hegasy G, Katzner K, Helle M, Mankertz A, Baumgarte S, Wille A, Fell G. Description of measles D4-Hamburg outbreak in Hamburg, Germany, December 2008 to June 2009, which disproportionally affected a local Roma community. Euro Surveill. 2012;17(24):20194. doi:10.2807/ese.17.24.20194-en.
  • Werber D, Hoffmann A, Santibanez S, Mankertz A, Sagebiel D. Large measles outbreak introduced by asylum seekers and spread among the insufficiently vaccinated resident population, Berlin, October 2014 to August 2015. Euro Surveill. 2017;22:30599. doi:10.2807/1560-7917.ES.2017.22.34.30599.
  • Bitzegeio J, Majowicz S, Matysiak-Klose D, Sagebiel D, Werber D. Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014/15: evidence for waning immunity. Euro Surveill. 2019;24:1800529. doi:10.2807/1560-7917.ES.2019.24.17.1800529.
  • Muscat M, Marinova L, Mankertz A, Gatcheva N, Mihneva Z, Santibanez S, Kunchev A, Filipova R, Kojouharova M. The measles outbreak in Bulgaria, 2009-2011: an epidemiological assessment and lessons learnt. Euro Surveill. 2016;21:30152. doi:10.2807/1560-7917.ES.2016.21.9.30152.
  • Pfaff G. Elimination of measles and rubella in Germany: progress and hindrances. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:1222–24. doi:10.1007/s00103-013-1803-5.
  • Schroder-Back P, Martakis K. Counterpoint: should childhood vaccination against measles be a mandatory requirement for attending school? No. Chest. 2015;148:854–56. doi:10.1378/chest.15-1162.
  • Neufeind J, Betsch C, Zylka-Menhorn V, Wichmann O. Determinants of physician attitudes towards the new selective measles vaccine mandate in Germany. BMC Public Health. 2021;21:566. doi:10.1186/s12889-021-10563-9.
  • Dascalu S. Measles Epidemics in Romania: lessons for Public Health and Future Policy. Front Public Health. 2019;7:98. doi:10.3389/fpubh.2019.00098.
  • Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. J Infect Dis. 2003;187(Suppl 1):S217–22. doi:10.1086/368228.
  • Ion-Nedelcu N, Craciun D, Pitigoi D, Popa M, Hennessey K, Roure C, Aston R, Zimmermann G, Pelly M, Gay N, et al. Measles elimination: a mass immunization campaign in Romania. Am J Public Health. 2001;91:1042–45.
  • Habersaat KB, Pistol A, Stanescu A, Hewitt C, Grbic M, Butu C, Jackson C. Measles outbreak in Romania: understanding factors related to suboptimal vaccination uptake. Eur J Public Health. 2020;30(5):986–92. doi:10.1093/eurpub/ckaa079.
  • Kriss JL, Stanescu A, Pistol A, Butu C, Goodson JL. The World Health Organization measles programmatic risk assessment Tool-Romania, 2015. Risk Anal. 2017;37:1096–107. doi:10.1111/risa.12669.
  • ECDC. Rapid risk assessment: ongoing outbreak of measles in Romania, risk of spread and epidemiological situation in EU/EEA countries. 2017 Mar 3. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-ongoing-outbreak-measles-romania-risk-spread-and.
  • Lazar M, Stanescu A, Penedos AR, Pistol A. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania. Euro Surveill. 2019;24:1900041. doi:10.2807/1560-7917.ES.2019.24.29.1900041.
  • Pitigoi D, Sandulescu O, Craciun MD, Draganescu A, Jugulete G, Streinu-Cercel A, Vișan A, Rîciu C, Rafila A, Aramă V. Measles in Romania - clinical and epidemiological characteristics of hospitalized measles cases during the first three years of the 2016-ongoing epidemic. Virulence. 2020;11:686–94. doi:10.1080/21505594.2020.1771948.
  • Miko D, Costache C, Colosi HA, Neculicioiu V, Colosi IA. Qualitative Assessment of Vaccine Hesitancy in Romania. Medicina (Kaunas). 2019;55:282. doi:10.3390/medicina55060282.
  • Mokhort H, Kovalchuk A, Sokolovska O, Higgs S. Contribution of Vaccination to the Reduction of Infectious Mortality in Ukraine in the Second Half of the 20(th) and Early 21(st) Century: a Comparative Population-Based Study of the Dynamics and Structure of Infectious Mortality and Incidence. Viral Immunol. 2018;31:695–707. doi:10.1089/vim.2018.0054.
  • Velicko I, Muller LL, Pebody R, Gergonne B, Aidyralieva C, Kostiuchenko N, Spika JS, et al. Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness. Vaccine. 2008;26:6980–85. doi:10.1016/j.vaccine.2008.09.012.
  • Spika JS, Aidyralieva C, Mukharskaya L, Kostyuchenko NN, Mulders M, Lipskaya G, Emiroglu N. Measles outbreak in the Ukraine, 2005-2006. Euro Surveill. 2006;11:E060309 1. doi:10.2807/esw.11.10.02918-en.
  • Bazylevych M. Vaccination campaigns in postsocialist Ukraine: health care providers navigating uncertainty. Med Anthropol Q. 2011;25:436–56. doi:10.1111/j.1548-1387.2011.01179.x.
  • Daragan GM, Krushinska TY, Stepanskiy DO, Demchyshyna IV, Kolesnikova IP. Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine. Medychni Perspektyvy. 2018;23:38–43. doi:10.26641/2307-0404.2018.1(part1).127206.
  • Smiianov VA, Zaitseva HS, Kurganskaya VA, Dyachenko AG, Zbarazhskyi VP, Smiianov YV, Pilipec OA. Vaccination coverage rates and the incidence of vaccine preventable diseases among children in sumy region of Ukraine. Wiad Lek. 2019;72:255–60. doi:10.36740/WLek201902121.
  • Koniushevska AA, Parkhomenko TA, Sharunova MV, Kazantsev AB, Yakovenko DV. Epidemiology and features of the measles course in children during the outbreak of 2018–2019 in the city of Mariupol. Regul Mech Biosyst. 2020;11:74–81. doi:10.15421/022010.
  • Romaniuk P, Semigina T. Ukrainian health care system and its chances for successful transition from Soviet legacies. Global Health. 2018;14:116. doi:10.1186/s12992-018-0439-5.
  • Colborne M. Tackling Pharma corruption in Ukraine. CMAJ. 2017;189:E1101–E2. doi:10.1503/cmaj.1095454.
  • Holt E. COVID-19 vaccination in Ukraine. Lancet Infect Dis. 2021;21:462. doi:10.1016/S1473-3099(21)00156-0.
  • Lekhan V, Rudiy V, Shevchenko M, Nitzan Kaluski D, Richardson E. Ukraine: health system review. Health Syst Transit. 2015;17:1–154.
  • WHO. Ukraine health reform: leapfrogging to modern health system. 2019. https://www.euro.who.int/__data/assets/pdf_file/0005/370850/pollab-ukraine-eng.pdf.
  • Wellcome-Trust. Wellcome Global Monitor 2018. Chapter 5: attitudes to vaccines. https://wellcome.org/reports/wellcome-global-monitor/2018/chapter-5-attitudes-vaccines.
  • Odone A, Dallagiacoma G, Frascella B, Signorelli C, Leask J. Current understandings of the impact of mandatory vaccination laws in Europe. Expert Rev Vaccines. 2021;20:559–75. doi:10.1080/14760584.2021.1912603.
  • Sabbatucci M, Odone A, Signorelli C, Siddu A, Maraglino F, Rezza G. Improved temporal trends of vaccination coverage rates in childhood after the mandatory vaccination act, Italy 2014–2019. J Clin Med. 2021;10:2540. doi:10.3390/jcm10122540.
  • Ecarnot F, Crepaldi G, Juvin P, Grabenstein J, Del Giudice G, Tan L, O’Dwyer S, Esposito S, Bosch X, Gavazzi G. Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting. BMC Public Health. 2019;19:1698. doi:10.1186/s12889-019-8044-y.
  • Bechini A, Garamella G, Giammarco B, Zanella B, Flori V, Bonanni P, Boccalini S. Paediatric activities and adherence to vaccinations during the COVID-19 epidemic period in Tuscany, Italy: a survey of paediatricians. J Prev Med Hyg. 2020;61:E125–E9. doi:10.15167/2421-4248/jpmh2020.61.2.1626.
  • Chiappini E, Parigi S, Galli L, Licari A, Brambilla I, Angela Tosca M, Ciprandi G, Marseglia G. Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: a narrative review. Acta Paediatr. 2021;110(9):2529–35. doi:10.1111/apa.15949.
  • Taine M, Offredo L, Drouin J, Toubiana J, Weill A, Zureik M, Dray-Spira R. Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020. Front Pediatr. 2021;9:666848. doi:10.3389/fped.2021.666848.
  • Guha-Sapir D, Moitinho de Almeida M, Keita M, Greenough G, Bendavid E. COVID-19 policies: remember measles. Science. 2020;369:261. doi:10.1126/science.abc8637.
  • Durrheim DN, Andrus JK, Tabassum S, Bashour H, Githanga D, Pfaff G. A dangerous measles future looms beyond the COVID-19 pandemic. Nat Med. 2021;27:360–61. doi:10.1038/s41591-021-01237-5.
  • Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2020;1–15.
  • ICense. iCense reveals the reasons of vaccination hesitancy in the Belgian population. 2021 Jun 27. https://www.icense.org/blog–press/icense-reveals-the-reasons-of-vaccination-hesitancy-in-the-belgian-population.
  • Di Gennaro F, Murri R, Segala FV, Cerruti L, Abdulle A, Saracino A, Bavaro DF, Fantoni M. Attitudes towards Anti-SARS-CoV2 vaccination among healthcare workers: results from a National Survey in Italy. Viruses. 2021;13:371. doi:10.3390/v13030371.